stockrow
Friday 6 November 2026
Export SNN’s income statement to Excel — free account
Smith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.
31.09
0.92
−2.87%
Follow SNN
Alert me
Smith & Nephew SNATS, Inc. (SNN) Revenue growth
Smith & Nephew SNATS, Inc.'s revenue growth over the twelve months to 30 June 2023 was 4.81%. Over the past ten years it has ranged from −11.3% (fiscal 2020) to 14.3% (fiscal 2021); the current reading is higher than 82% of that period. That is below the Medical Devices industry median of 10.4% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.09% | 1.39 |
| FY2024 | 4.70% | (1.70) |
| FY2023 | 6.40% | 6.34 |
| FY2022 | 0.06% | (14.24) |
| FY2021 | 14.3% | 25.55 |
| FY2020 | −11.3% | (16.02) |
| FY2019 | 4.77% | 1.85 |
| FY2018 | 2.92% | 0.86 |
| FY2017 | 2.06% | 1.30 |
| FY2016 | 0.76% | 0.39 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2023 | 7.99% | 6.71 |
| Dec 2022 | 1.28% | (19.86) |
| Jun 2022 | 21.1% | 27.69 |
| Dec 2021 | −6.55% | (13.42) |
| 6 more quarters | Free account |
Against its own ten years
Low −11.3%
High 14.3%
Ten-year median
2.92%
Current reading's percentile
82
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GKOS Glaukos Corporation compare | 46.9% |
| PODD Insulet Corporation compare | 26.5% |
| PEN Penumbra, Inc. compare | 17.0% |
| GMED Globus Medical, Inc. compare | 13.4% |
| SNN Smith & Nephew SNATS, Inc. | 4.81% |
| BRKR Bruker Corporation compare | 2.16% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.38% |
| BIO Bio-Rad Laboratories, Inc. compare | 1.38% |
| TXG 10x Genomics compare | −4.28% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on SNN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement